XML 66 R41.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of Valuation Assumptions
The weighted average assumptions used in the Black-Scholes option-pricing model for the years ended December 31, 2019 and 2018, are set forth below:

 
Year Ended December 31, 2019
 
Year Ended December 31, 2018
Expected term (in years)
6.25

 
6.25

Expected volatility
42.2
%
 
44.8
%
Risk-free interest rate
2.5
%
 
2.8
%
Expected dividend
—

 
—

Weighted average fair value at grant date
$
4.28

 
$
7.30
Schedule of Stock Options
Information related to the stock options granted during the years ended December 31, 2019 and 2018 is as follows:
 
2017 Stock Incentive Plan
 
Options
 
Weighted Average Exercise Price
 
Aggregate Intrinsic Value
 
 
 
 
 
(in thousands)
Outstanding at December 31, 2017
224,355

 
$
14.01

 
$
189

Options exercisable at December 31, 2017
—

 
$
—

 
 
Options granted
340,558

 
15.39

 
 
Options exercised
(1,641
)
 
11.27

 
 
Options canceled/forfeited
(29,689
)
 
14.77

 
 
Outstanding at December 31, 2018
533,583

 
$
14.86

 
$
—

Options exercisable at December 31, 2018
53,497

 
$
14.09

 
 
Options granted
723,951

 
9.55

 
—

Options exercised
(11,438
)
 
14.08

 
63

Options canceled/forfeited
(14,871
)
 
12.92

 
4

Outstanding at December 31, 2019
1,231,225

 
$
11.76

 
$
9,341

Vested and expected to vest at December 31, 2019
1,231,225

 
$
11.76

 
$
9,341

Options exercisable at December 31, 2019
170,139

 
$
14.68

 
$
795
Schedule of Nonvested Share Activity
A summary of the Company’s non‑vested stock options for the years ended December 31, 2019 and 2018 is as follows:
Non-vested Options
Options
 
Weighted Average Grant Date Fair Value
December 31, 2017
224,355

 
$
7.02

     Granted
340,558

 
7.30

     Vested
(55,919
)
 
7.02

     Canceled/forfeited
(28,908
)
 
7.20

December 31, 2018
480,086

 
$
7.21

     Granted
723,951

 
4.28

     Vested
(131,696
)
 
7.21

     Canceled/forfeited
(11,255
)
 
5.32

December 31, 2019
1,061,086

 
$
5.23
Schedule of Options Exercisable
The following tabulation summarizes certain information about outstanding and exercisable stock options at December 31, 2019:
 
Options Outstanding
 
Options Exercisable
Range of Exercise Prices
December 31, 2019
 
Weighted Average Remaining Contractual Life in Years
 
Weighted Average Exercise Price
 
December 31, 2019
 
Weighted Average Exercise Price
$9.00 - $12.99
713,922

 
9.1
 
$
9.45

 
27

 
$
11.27

$13.00 - $14.99
187,324

 
7.1
 
14.00

 
90,610

 
14.00

$15.00 - $18.99
329,979

 
8.2
 
15.50

 
79,502

 
15.45

 
1,231,225

 
8.6
 
$
11.76

 
170,139

 
$
14.68
Schedule of Restricted Stock Units
The following table summarizes all unvested restricted stock unit activity for the years ended December 31, 2019 and 2018:
 
Restricted Stock Units Outstanding
 
Weighted Average Grant Date Fair Value
Unvested balance at December 31, 2017
128,815

 
$
14.18

Granted
286,808

 
15.16

Vested
(50,355
)
 
14.55

Canceled/forfeited
(15,754
)
 
14.82

Unvested balance at December 31, 2018
349,514

 
$
14.90

Granted
517,611

 
9.65

Vested
(100,779
)
 
15.06

Canceled/forfeited
(12,048
)
 
12.52

Unvested balance at December 31, 2019
754,298

 
$
11.31
Stock Based Compensation Expense
The following table summarizes the amounts recognized in the consolidated financial statements for the year ended December 31, 2019 for total stock-based compensation expense (in thousands):
 
 
Year Ended December 31, 2019
Total stock-based compensation expense
 
$
4,187

Income tax benefit recognized in earnings
 
(917
)
Total stock-based compensation expense, net of tax
 
$
3,270